聚和(6509)股價上漲，大漲帶動＋短盤中上漲7.88%，逼近報43.8元，％生買盤明顯迴流。物緩今日走強主因仍圍繞在生物緩衝劑長線成長題材與屏東新廠擴產想像，衝劑成長市場把聚和視為兼具精密化學與生技應用的題材題材股，在近期大盤震盪中，買盤面轉資金重新鎖定具成長性且評價仍不算過熱的迴流個股。輔因則來自今年以來營收結構改善，離壓力區1、即時聚和技術3月營收呈現年成長與高檔水準，新聞線脫緩和先前營收起伏帶來的股價okex易所钱包平台疑慮，使得短線承接意願升溫，推動股價在前幾日40元附近整理後出現一波急拉。
技術面來看，聚和近期股價自30多元區間一路墊高至40元上方，高檔震盪後再度發動攻勢，現價已明顯站上前一交易日收盤價與近期整理區上緣，短線多方結構轉強。不過從中長期角度，股價先前自45元以上壓回，月線與季線仍在上方，代表中長期均線壓力並未完全化解。籌碼面部分，近日三大法人雖有買超回補，但主力近月多空拉扯明顯，先前在45元附近有較重的主力與籌碼套牢區，短線追價宜留意上方套牢解壓過程。後續關鍵留意股價能否穩守40元上方，並進一步挑戰前波高檔壓力帶。
聚和屬化學工業族群，為全球前三大的自黏便利貼製造商，同時是造紙化學品與特用、精密化學品的重要供應商，近年積極切入生物緩衝劑市場，搭上生技與國際化學品需求擴張的長線趨勢。綜合今日盤中走勢與基本面題材，股價在生物緩衝劑擴產與營收回升加持下，短線多方佔優，但中長期仍面對國際景氣、化學品價格波動與電動車、紙業需求起伏等風險。後續觀察重點在於：營收能否延續高檔成長、擴產進度與接單明確度，以及股價在40～45元區間的量價變化，是否出現健康換手後再啟一波趨勢行情。
👉🏻下載【籌碼K線】，一圖秒懂現在誰在買！
追蹤法人、大戶、主力動向，全盤行情不漏接。
Disclaimer: All text and images published on this site are adapted or collected from the Internet. We do not use them for any commercial purpose, and the copyright belongs to the original author. Since we cannot contact the copyright holders for some content, please contact us to delete it if it infringes or involves illegality. Please keep the original address for reprinting: http://baxibingjiling.com/news/088c7099841.html
Featured Reads
欧易交易所官网
欧易交易所平台
A professional relationship recovery organization in China, providing a platform for people to learn and communicate about emotions. We offer practical knowledge including dating skills, marriage experience, relationship recovery, as well as professional emotional counseling and one-on-one guidance services.
Scan to Follow WeChat
